Express Scripts Holding Co (ESRX)

60.01
7.24 10.77
NASDAQ : Health Care
Prev Close 67.25
Open 58.72
Day Low/High 57.80 / 61.17
52 Wk Low/High 65.55 / 94.22
Volume 36.84M
Avg Volume 4.36M
Exchange NASDAQ
Shares Outstanding 600.31M
Market Cap 39.90B
EPS 5.40
P/E Ratio 12.33
Div & Yield N.A. (N.A)

Latest News

Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement

Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement

Express Scripts is losing its largest customer.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Express Scripts Holding Company

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Express Scripts Holding Company

Levi & Korsinsky, LLP announces it has commenced an investigation of Express Scripts Holding Company ("Express Scripts") (NASDAQ:ESRX) concerning possible violations of federal securities laws.

Stocks Hold at Highs as Dow, S&P 500 Enjoy Best Two-Day Stretch of 2017

Stocks Hold at Highs as Dow, S&P 500 Enjoy Best Two-Day Stretch of 2017

Better-than-expected earnings from industry leaders including Caterpillar and McDonald's push the Dow to log triple-digit gains for the second day in a row, its best two-day stretch of the year.

SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Express Scripts Holding Company And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Express Scripts Holding Company And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company") (Nasdaq: ESRX) concerning possible violations of federal securities...

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

U.S. stock futures are set for solid gains and European stocks soar after the first round of France's elections put centrist Emmanuel Macron in the lead for the presidency.

Market Recon: The World Is Agog With 'Risk-on' Behavior

Market Recon: The World Is Agog With 'Risk-on' Behavior

But also remember that this week earnings will run wild, with nearly 200 members of the S&P 500 reporting.

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Here are five things you must know for Monday, April 24.

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Express Scripts: A Prescription for Value

Express Scripts: A Prescription for Value

Its earnings are more than double what they were five years ago, but the stock price is the same.

Mango Health Announces Partnership, Strategic Investment From Express Scripts

Mango Health Announces Partnership, Strategic Investment From Express Scripts

New daily health solution connects two industry leading platforms for improving health outcomes and reducing the cost of care.

Politicians Question EpiPen Competitor's High Pricetag

Politicians Question EpiPen Competitor's High Pricetag

Chuck Grassley is hammering the privately held drug company on its $4,500 EpiPen competitor.

Market Recon: President Trump's Speech Will Dominate Trading

Market Recon: President Trump's Speech Will Dominate Trading

I believe this president goes full Trumpian tonight, in a style that he has made all his own.

Here's Why AmerisourceBergen Is Up 16% This Year

Here's Why AmerisourceBergen Is Up 16% This Year

The pharmaceutical distributor is finally turning around.

What We Need to Know: Express Scripts Q4 Earnings

What We Need to Know: Express Scripts Q4 Earnings

It used the earning's call to pass much of the blame for high drug prices onto pharmaceutical companies.

Express Scripts: Rx For Earnings Growth

Express Scripts: Rx For Earnings Growth

The country's largest pharmacy benefits manager is enjoying tailwinds after reporting a big jump in year-over-year profits.

Express Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing

Express Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing

The pharmacy benefit manager shifted blame for drug pricing back to pharma companies.

How Kaleo Pharma Prices Its EpiPen Competitor

How Kaleo Pharma Prices Its EpiPen Competitor

Kaleo's EpiPen compeitor the Auvi-Q was released today.

Mylan Shares Unchanged as Kaleo Releases EpiPen Competitor

Mylan Shares Unchanged as Kaleo Releases EpiPen Competitor

The Auvi-Q was released Feb. 14, but it's unclear whether patients will break up with their current option, EpiPen, for something new.

Bearish Bets: A PBM, a Regional Airline and Other Stocks That Look Good Short

BLL, OPK, ESRX, SKYW and DLA all were recently downgraded by TheStreet's Quant Ratings.

Barclays, Banco Santander, Amgen, UnitedHealth Group: 'Mad Money' Lightning Round

Barclays, Banco Santander, Amgen, UnitedHealth Group: 'Mad Money' Lightning Round

Jim Cramer likes European banks, plus Banco Santander, and New York Community Bancorp, too.

Analyzing Risks Posed by a Possible Trump Correction: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Analyzing Risks Posed by a Possible Trump Correction: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer takes a closer look at the risks: Don't measure 'Trump per share,' measure actual earnings per share.